Odisha signs MoU with PMSRF for free cardiac treatment of children
Odisha Chief Minister Naveen Patnaik, Justice Vineet Saran, Judge, Supreme Court of India, Justice Mohammad Rafiq, Chief Justice of Orissa High Court, Justice Kalpesh Jhaveri, former Chief Justice of Orissa HC and state Health and Family Welfare Minister NK Das were present during the signing of the MoU on Thursday.
Stent maker Sahajanand to sell 30% stake, eyes $300 mn valuation
Established in 1998, SMT develops and manufactures cardiac products that are...
Regulate medical devices in phased manner: Companies
The National Pharmaceuticals Pricing Authority (NPPA) has called a meeting with stakeholders on July 1 to ensure that medical devices aren’t overpriced. The Centre had said earlier this year that all medical devices sold locally would be treated as drugs under the Drugs and Cosmetics Act with effect from April 1.
Over 1 crore people have availed free treatment under Ayushman Bharat so far: NHA
Also, 2,132 patients have availed or are currently undergoing treatment for COVID-19 under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojna (AB-PMJAY) in the country, the National Health Authority (NHA), which is responsible for implementing the scheme, said on Wednesday.
Drug price regulator exempts Meril Life Sciences from price controls for a stent developed 3 years ago
This means that the firm has provided adequate justification to the government for launching its product at “any price" it wants. Meril Life’s first locally made biodegradable cardiac scaffold, a naturally dissolving stent, known as MeRes100 will be expected from price controls for the next five years.
Stents price capping has improved its accessibility: Drug pricing regulator NPPA
According to the National Pharmaceutical Pricing Authority (NPPA) both stent manufactured and imported went up from 9.36 lakh in 2016 to 13.55 lakh in 2019. ”Indicating increased access because of price capping by NPPA. After a few revisions in last three years, a bare metal stent (BMS) is currently priced at Rs 8,261, and a drug eluting stent (DES) costs Rs 30,080.
After price cap, local stent makers capture 60% of market
Price regulation has also allowed better margins to Indian companies even as locally made, lower-priced products gain in the market, helping local players increase revenues. The share of Indian companies in terms of value has increased from 30% in 2016-17 to over 55% in 2019-20.
NPPA defers decision on Meril’s stent pricing plea
Meril Life’s first locally made biodegradable cardiac scaffold, a naturally dissolving stent, is known as MeRes100. The stent was approved by the Drug Controller General of India in 2017, when prices were cut, prompting Meril, based in Vapi, Gujarat, to hold back on launching the product.
Panel likely to study stent companies' demand on price cap
With the committee not finding any “therapeutic advantage” in these stents that favours price exemption, the issue is likely to be sent to an inter-ministerial group of experts.
Patients' group opposes stent categorisation
In April 2015 and January 2018, expert committees examining the request for separate categories for 'innovative' stents had decided that there was no case for sub-categorisation due to the lack of clinical evidence of superiority of the 'innovative' stents over other drug eluting stents.
Govt considering to let US companies make medical devices in India
India is mulling a proposal to ask American companies to produce medical devices locally.
Government to drop 500 existing health packages, include 250 new ones
The discontinued packages include renal angioplasty with single stent (medicated) and eversion of hydrocele sac — unilateral.
Hospitals still not displaying medical device prices, consumer groups say
As per survey, 50% of the respondents said that medical devices they came across, did not have MRPs.
Made in India coronary stents as good as foreign ones: Study
The study dispels the perception among many doctors and patients that stents made in India may not be as safe and efficacious as those manufactured in foreign countries.